May 19th, 2015
By Scott Plevy, M.D., Disease Area Stronghold Leader, Inflammatory Bowel Disease (IBD), and Sean Larkin, Disease Area Stronghold Commercial Leader, IBD, Janssen
Today, May 19th, the Janssen Pharmaceutical Companies of Johnson & Johnson recognize World Inflammatory Bowel Disease (IBD) Day, an annual event to raise awareness and support the five million people living with Crohn’s disease and ulcerative colitis (UC).
At Janssen, we work each and every day to improve the lives of people living with Crohn’s disease and UC—a passion that’s inspired us for more than two decades.
Guided by the conviction that there are no limits to science, we recognize that, despite our successes, we can do more for patients. As innovators and collaborators, we are committed to treating, intercepting and, one day, curing IBD.
We hope that you support World IBD Day and join the conversation on Twitter and LinkedIn by sharing what a world free from IBD means to you using #aworldfreefrom.